Pitolisant is approved for treatment of
Pitolisant is a new drug approved for treatment of excessive day time sleepiness in patients with narcolepsy. It acts as inverse agonist of H3 receptors of histamine. New drugs recently approved for conditions mentioned in options are:* Tenosynol giant cell tumor: Pexidainib* Polyneuropathy in transthyretin amyloidosis: Tafamidis meglumine* Primary and secondary myelofibrosis: Fedratinib
Tenosynol giant cell tumor
Excessive day time sleepiness in patients with narcolepsy
Polyneuropathy due to transthyretin amyloidosis
Primary myelofibrosis
Sedative-Hypnotics and Parkinsonism